A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512

Clinical trial NCT05493111 · COMPLETED

Trial details

NCT number: NCT05493111
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-11-01
Primary completion: 2024-02-28
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.